EUVIMEDEUVIMED entdecken
LeserbriefKommentar

Bleeding in Patients With Atrial Fibrillation—Reply

Wayne A Ray, C Michael Stein, Katherine T Murray

JAMA · 2024

DOI: 10.1001/jama.2024.13792 ↗

Kurz gefasst

Leserbrief in der Zeitschrift JAMA, 2024. Verfasst von Wayne A Ray und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Policy, Vanderbilt University School of Medicine, Nashville, Tennessee. Hauptthemen laut MEDLINE: Anticoagulants, Atrial Fibrillation, Hemorrhage. Die Arbeit nennt 2 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticoagulantsAtrial FibrillationHemorrhageHumansStrokeSex FactorsMaleFemaleAdministration, OralDiltiazemDrug InteractionsRivaroxaban

Substanzen

AnticoagulantsDiltiazemRivaroxaban

Autor:innen und Institutionen

  • Department of Health Policy, Vanderbilt University School of Medicine, Nashville, Tennessee.
  • Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.

Zitieren

APA

Ray, W. A., Stein, C. M., & Murray, K. T. (2024). Bleeding in Patients With Atrial Fibrillation—Reply. JAMA. https://doi.org/10.1001/jama.2024.13792

Vancouver

Ray WA, Stein CM, Murray KT. Bleeding in Patients With Atrial Fibrillation—Reply. JAMA. 2024. doi:10.1001/jama.2024.13792

BibTeX
@article{Ray2024,
  author = {Ray, Wayne A and Stein, C Michael and Murray, Katherine T},
  title = {Bleeding in Patients With Atrial Fibrillation—Reply},
  journal = {JAMA},
  year = {2024},
  doi = {10.1001/jama.2024.13792}
}
Kostenlos starten →